MARKET

IPSEF

IPSEF

Ipsen Promesses
OTCPK
117.60
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
117.60
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
117.60
52 WEEK LOW
117.60
MARKET CAP
9.73B
P/E (TTM)
18.62
1D
5D
1M
3M
1Y
5Y
1D
Genfit adds $20M as Ipsen records strong sales for liver drug
Seeking Alpha · 4d ago
Ipsen S.A. Non-GAAP EPS of €12.09, revenue of €3.68B; sets full-year 2026 guidance and mid-term outlook
Seeking Alpha · 5d ago
Ipsen rises on FDA breakthrough therapy status for blood cancer therapy
Seeking Alpha · 01/14 11:57
What To Expect From Gilead In Q3 2025
Seeking Alpha · 10/24/2025 14:56
Ipsen S.A. reports Q3 results; upgrades FY outlook
Seeking Alpha · 10/22/2025 07:09
Weekly Report: what happened at IPSEF last week (0908-0912)?
Weekly Report · 09/15/2025 09:55
Weekly Report: what happened at IPSEF last week (0901-0905)?
Weekly Report · 09/08/2025 09:56
Weekly Report: what happened at IPSEF last week (0825-0829)?
Weekly Report · 09/01/2025 09:54
More
About IPSEF
Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.

Webull offers Ipsen SA stock information, including OTCPK: IPSEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPSEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPSEF stock methods without spending real money on the virtual paper trading platform.